Hikma Pharmaceuticals PLC (HKMPY)
USD 48.77
(0.0%)
USD 48.77
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 608 Million | 530 Million | 638 Million | 464 Million | 472 Million | 430 Million |
| Net Income | 281 Million | 233 Million | 544 Million | 558 Million | 491 Million | 293 Million |
| Depreciation & Amortization | 259 Million | 193 Million | 145 Million | 91 Million | 99 Million | 121 Million |
| Deferred income taxes | -125 Million | - | -89 Million | -26 Million | -99 Million | -57 Million |
| Stock-based compensation | 25 Million | 22 Million | 29 Million | 27 Million | 24 Million | 21 Million |
| Change in working capital | 80 Million | -131 Million | -30 Million | -208 Million | -44 Million | -25 Million |
| Other non-cash items | 88 Million | 213 Million | 39 Million | 22 Million | 1 Million | 77 Million |
| Investing Cash Flow | -333 Million | -607 Million | -238 Million | -283 Million | -151 Million | -96 Million |
| Investments in PPE | -204 Million | -225 Million | -229 Million | -224 Million | -186 Million | -139 Million |
| Acquisitions | -105 Million | -380 Million | -17 Million | -60 Million | 19 Million | 27 Million |
| Investment purchases | -27 Million | -15 Million | -3 Million | -5 Million | -6 Million | -4 Million |
| Sales/Maturities of investments | 1 Million | - | 6 Million | 2 Million | 14 Million | 4 Million |
| Other Investing Activities | 2 Million | 13 Million | 5 Million | 4 Million | 8 Million | 16 Million |
| Financing Cash Flow | -337 Million | -58 Million | -287 Million | -298 Million | -155 Million | -278 Million |
| Debt repayment | -1.3 Billion | -1.32 Billion | -476 Million | -1.73 Billion | -284 Million | -372 Million |
| Dividends payments | -137 Million | -125 Million | -120 Million | -109 Million | -97 Million | -84 Million |
| Common Stock Repurchased | - | -300 Million | - | -375 Million | - | - |
| Common Stock Issuance | - | - | - | 1.92 Billion | - | - |
| Other Financing Activities | 1.1 Billion | 1.69 Billion | 309 Million | -1 Million | 226 Million | 178 Million |
| Accounts receivables | -24 Million | 4 Million | -166 Million | -47 Million | 21 Million | -41 Million |
| Accounts payables | 88 Million | 16 Million | 14 Million | 6 Million | -6 Million | 88 Million |
| Inventory | -115 Million | -102 Million | 38 Million | -180 Million | -25 Million | -51 Million |
| Other working capital | 131 Million | -49 Million | 84 Million | 13 Million | -34 Million | -21 Million |
| Cash at beginning of period | 270 Million | 426 Million | 323 Million | 442 Million | 276 Million | 227 Million |
| Cash at end of period | 205 Million | 270 Million | 426 Million | 323 Million | 442 Million | 276 Million |
| Capital Expenditure | -204 Million | -225 Million | -229 Million | -224 Million | -186 Million | -139 Million |
| Effect of forex changes on cash | -3 Million | -21 Million | -10 Million | -2 Million | - | -7 Million |
| Net cash flow / Change in cash | -65 Million | -156 Million | 103 Million | -119 Million | 166 Million | 49 Million |
| Free Cash Flow | 404 Million | 305 Million | 409 Million | 240 Million | 286 Million | 291 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 226 Million | 281 Million | 58.53 Million | 131 Million | 233 Million | 15.73 Million |
| Depreciation & Amortization | 102 Million | 259 Million | 94.24 Million | 96 Million | 193 Million | 101.74 Million |
| Deferred income taxes | - | -125 Million | -125.08 Million | -331 Million | - | -197.51 Million |
| Stock-based compensation | 15 Million | 25 Million | 15 Million | 10 Million | 22 Million | 12 Million |
| Change in working capital | -223 Million | 80 Million | 194.36 Million | -115 Million | -131 Million | 7.58 Million |
| Other non-cash items | 78 Million | 88 Million | 105.7 Million | 395 Million | 213 Million | 405.2 Million |
| Investing Cash Flow | -106 Million | -333 Million | -215.29 Million | -122 Million | -607 Million | -132.86 Million |
| Investments in PPE | -69 Million | -204 Million | -95.37 Million | -107 Million | -225 Million | -117.01 Million |
| Acquisitions | -1 Million | -105 Million | -85.3 Million | -1 Million | -380 Million | -18.26 Million |
| Investment purchases | -2 Million | -27 Million | -21.78 Million | -5 Million | -15 Million | 2.26 Million |
| Sales/Maturities of investments | - | 1 Million | -7946.54 | 1 Million | - | 1.00 |
| Other Investing Activities | -37 Million | 2 Million | -12.81 Million | -10 Million | 13 Million | 146.86 Thousand |
| Financing Cash Flow | -52 Million | -337 Million | -193.97 Million | -59 Million | -58 Million | -307.51 Million |
| Debt repayment | -47 Million | -1.3 Billion | -121.26 Million | -29 Million | -1.32 Billion | -240.92 Million |
| Dividends payments | -104 Million | -137 Million | -53.91 Million | -82 Million | -125 Million | -48.11 Million |
| Common Stock Repurchased | - | - | - | - | -300 Million | -11.68 Million |
| Common Stock Issuance | - | - | - | - | - | -5.44 Million |
| Other Financing Activities | 5 Million | 1.1 Billion | -13.88 Million | -1 Million | 1.69 Billion | -1.34 Million |
| Accounts receivables | -130 Million | -24 Million | 51.19 Million | -75 Million | 4 Million | 11.19 Million |
| Accounts payables | -24 Million | 88 Million | 55.3 Million | 32 Million | 16 Million | 35.78 Million |
| Inventory | -66 Million | -115 Million | -28.08 Million | -86 Million | -102 Million | -28.99 Million |
| Other working capital | -27 Million | 131 Million | 115.95 Million | 14 Million | -49 Million | -10.39 Million |
| Cash at beginning of period | 205 Million | 270 Million | 272 Million | 270 Million | 426 Million | 371 Million |
| Cash at end of period | 236 Million | 205 Million | 205 Million | 272 Million | 270 Million | 270 Million |
| Capital Expenditure | -69 Million | -204 Million | -95.37 Million | -107 Million | -225 Million | -117.01 Million |
| Effect of forex changes on cash | -9 Million | -3 Million | -492.68 Thousand | -3 Million | -21 Million | -12 Million |
| Net cash flow / Change in cash | 31 Million | -65 Million | -67 Million | 2 Million | -156 Million | -101 Million |
| Free Cash Flow | 129 Million | 404 Million | 247.38 Million | 79 Million | 305 Million | 227.74 Million |
FBCPF
0Y5E
VLID3
300110
DPUM
GGPS3